|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cardiovascular Diseases | |||||
| Coronary Arteriosclerosis | |||||
| Coronary Disease | |||||
| Heart Diseases | |||||
| Hypercholesterolemia | |||||
| Hypertension | |||||
| Myocardial Ischemia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Arteriosclerosis | |||||
| Coronary Artery Disease | |||||
| Ischemia | |||||
| 3 | More general conditions related to this trial | ||||
| Arterial Occlusive Diseases | |||||
| Dyslipidemias | |||||
| Hyperlipidemias | |||||
| Lipid Metabolism Disorders | |||||
| Metabolic Diseases | |||||
| Pathologic Processes | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| diet, vegetarianism | |||||
| diet, fat-restricted | |||||
| exercise | |||||
| smoking cessation | |||||
| 5 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||